02/06/2021
Ministry of Health Announcement:
The Director-General of the Ministry of Health, Prof. Hezi Levi, has finalized the MoH's position, together with the approval of the Minister of Health, regarding expanding vaccinations to adolescents between the ages of 12-16.
A meeting of the Pandemic Response Team (PRT) and the Vaccine Monitoring Committee was held last night, headed by the MoH's Dir. Gen., Prof. Hezi Levi, together with Covid Czar Prof. Nahman Ashe, Dr. Boaz Lev - PRT Director, representatives of the Association of Pediatricians in Israel, and experts on vaccination and epidemiology.
A long discussion was held, during which the various professionals and experts reviewed the multidisciplinary study discussing possible complications from expanding vaccinations, including myocarditis.
IT should be noted that pursuant to the details provided yesterday, the risks stemming from Covid are higher than those stemming from receiving the vaccine. Even those cases of myocarditis observed in recipients age 16-19 were few in number and in most cases, resolved without complications.
With that, in light of the fact that Covid morbidity in Israel is very low, it was decided to recommend vaccinating high-risk groups as soon as possible, including adolescents with a high risk of severe Covid, those living with high-risk family members, as well as families expecting to travel overseas.
In addition to these high-risk groups, it shall be possible to vaccinate anyone wishing to do so.
The vaccine is safe and effective.
The Dir. Gen. of the MoH is currently holding logistical preparation discussions with the various health funds to vaccinate adolescents.
Vaccinations for adolescents are expected to commence next week through the health funds.
The MoH will continue to provide updates as necessary.